PaxVax, Inc.

Start Date

End Date Funded Value Relevance

CSV

25 50 100

£939,055

Aug 15 - Oct 20

MICA: Ad4HIV, A Phase I Trial Investigating Ad4, MVA and Protein Immunisation Strategies to Maximise Protective Antibody Responses to HIV-1 Envelope

MRC award to Imperial College London and Robin Shattock

{{facetGroup.name}}

{{getFilterText(facet,showCount)}}